col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Research and Practice in Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―28 Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin
2 [GO] 2021―May―19 Comparison of the coagulopathies associated with COVID-19 and sepsis Robert A. Campbell, Yohei Hisada, Frederik Denorme, Steven P. Grover, Emma G. Bouck, Elizabeth A. Middleton, et al. (+3)
3 [GO] 2021―May―08 Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study Lachelle D. Weeks, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell
4 [GO] 2021―Mar―08 Caging the dragon: Research approach to COVID-19-related thrombosis Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. Gorp, Nicole P. Juffermans, Frederikus A. Klok, et al. (+2)
5 [GO] 2021―Feb―24 Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19 Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, et al. (+6)
6 [GO] 2021―Feb―18 Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients MAM Stals, MJJH Grootenboers, C van Guldener, FHJ Kaptein, SJE Braken, Q Chen, et al. (+10)
7 [GO] 2021―Jan―15 Vascular thromboembolic events following COVID-19 hospital discharge: incidence and risk factors Harish Eswaran, Jamie A. Jarmul, Amy W. Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
8 [GO] 2021―Jan―05 COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy Alice Assinger
9 [GO] 2020―Dec―07 Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality Fien A. Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann-Sofie Rudberg, Maria Magnusson, et al. (+3)
10 [GO] 2020―Nov―10 eThrombosis: A new risk factor for venous thromboembolism in the pandemic era Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita
11 [GO] 2020―Oct―21 Harmonizing Hypercoagulable Heterogeneity: Baseline VTE Risk in COVID-19 George Goshua, Alfred Ian Lee
12 [GO] 2020―Sep―28 COVID-19 pandemic perspectives: A scientific silver lining? Dre'Von A. Dobson, Alisa S. Wolberg
13 [GO] 2020―Sep―25 Thrombo-inflammation response to Tocilizumab in COVID-19 Mansour Gergi, Mary Cushman, Benjamin Littenberg, Ralph C. Budd
14 [GO] 2020―Sep―25 Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay
15 [GO] 2020―Sep―19 Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients Nithita Nanthatanti, Sithakom Phusanti, Pichika Chantrathammachart, Kanin Thammavaranucupt, Pantep Angchaisuksiri, Somnuek Sungkanuparph
16 [GO] 2020―Jul―14 The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Jori E. May, Rance C. Siniard, Marisa Marques
17 [GO] 2020―Jul―11 Thrombosis and coagulopathy in COVID-19: An illustrated review Marcel Levi, Beverley J. Hunt
18 [GO] 2020―Jul―09 Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
19 [GO] 2020―Jul―09 Anticoagulation Practice Patterns in COVID-19: A Global Survey Rachel P. Rosovsky, Kristen M Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, et al. (+8)
20 [GO] 2020―Jun―25 Staying updated on COVID-19: social media to amplify science in thrombosis and haemostasis Mike Makris
21 [GO] 2020―Jun―14 The underrecognized prothrombotic vascular disease of COVID-19 Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos
22 [GO] 2020―Jun―08 Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis Mary Cushman
23 [GO] 2020―May―29 Anticoagulation, Immortality, and Observations of COVID-19 Jason H. Maley, Camille R. Petri, Laura N. Brenner, Raghu R. Chivukula, Tiara F. Calhoun, Vladimir Vinarsky, C. Corey Hardin
24 [GO] 2020―May―29 Potential Role of Platelets in COVID-19: Implications for Thrombosis Milka Koupenova
25 [GO] 2020―May―21 STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhnuwala, Robert C. McIntyre, Peter K Moore, et al. (+5)
26 [GO] 2020―May―20 Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 Adult Respiratory Distress Syndrome Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
27 [GO] 2020―May―20 Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a University Hospital Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay
28 [GO] 2020―May―14 Venous Thromboembolism in Critically Ill Patients with Covid-19: Results of a Screening Study for Deep Vein Thrombosis Alban Longchamp, Justine Longchamp, Sara Manzocchi-Besson, Livia Whiting, Claude Haller, Séverin Jeanneret, et al. (+16)
29 [GO] 2020―May―11 A Proposal for Staging COVID-19 Coagulopathy Jecko Thachil, Mary Cushman, Alok Srivastava
30 [GO] 2020―May―06 Thrombosis and Thromboembolism Related to COVID-19 A clarion call for obtaining solid estimates from large-scale multicenter data Stefano Barco, Stavros V Konstantinides
31 [GO] 2020―May―04 COVID-19 Hypothesis: Activated Protein C for Therapy of Virus-induced Pathologic Thromboinflammation John H. Griffin, Patrick Lyden
32 [GO] 2020―Apr―28 Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, John Burke, et al. (+7)
33 [GO] 2020―Apr―28 Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019 Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos
34 [GO] 2020―Apr―21 COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Suzanne C Cannegieter, Frederikus A Klok
35 [GO] 2020―Apr―18 The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19 JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, et al. (+4)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.012 sec